Andrzej Andraczke's most recent trade in Cns Pharmaceuticals Inc was a trade of 32,000 Option to purchase common stock done . Disclosure was reported to the exchange on July 15, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cns Pharmaceuticals Inc | Andrzej Andraczke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 32,000 | 178,559 | - | - | Option to purchase common stock |